Stockreport

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract [Yahoo! Finance]

Pluri Inc.  (PLUR) 
PDF option for the second year of the contract has been exercise d to fund manufacturing in-vitro and in-vivo studies of Pluri's cell therapy PLX-R18 is designed to be a f [Read more]